Literature DB >> 20607302

Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease.

Anja K Büscher1, Rainer Büscher, Berthold P Hauffa, Peter F Hoyer.   

Abstract

Protein-energy wasting is a common problem in pediatric patients with chronic kidney disease (CKD). Disturbances in appetite-regulating hormones have been suggested as causative factors. Acyl ghrelin is a potent orexigenic hormone, whereas desacyl ghrelin and obestatin have the opposite effect. The regulation of acyl ghrelin and its anorexigenic opponents and its role in the development of CKD-associated protein-energy wasting is poorly understood. We measured total and acylated ghrelin, obestatin, leptin, and adiponectin in children with CKD (n=29), children undergoing hemodialysis (HD) or peritoneal dialysis (PD; n=29), renal transplant recipients (RTx; n=91), and healthy controls (n=27), and analyzed the data in relation to body mass index (BMI) and height. Patients with renal insufficiency showed lower BMI standard deviation score (SDS) values and height SDS compared with controls and RTx patients. Total ghrelin was elevated in CKD and dialyzed patients compared with controls or transplant recipients (P<0.001). Acyl ghrelin did not differ between groups, and the acyl ghrelin/total ghrelin ratio was reduced in uremic patients (P<0.05). Obestatin plasma levels were increased in patients with renal insufficiency compared with controls and RTx patients (P<0.01). Uremia leads to an accumulation of the anorexigenic hormones desacyl ghrelin and obestatin. Orexigens like acyl ghrelin are not elevated. A disturbed balance between anorexigenic and orexigenic hormones may influence development of CKD-associated protein-energy wasting in pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607302     DOI: 10.1007/s00467-010-1588-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Anorexia in hemodialysis patients: an update.

Authors:  M Bossola; L Tazza; S Giungi; G Luciani
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

3.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

4.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

5.  Ghrelin strongly stimulates growth hormone release in humans.

Authors:  K Takaya; H Ariyasu; N Kanamoto; H Iwakura; A Yoshimoto; M Harada; K Mori; Y Komatsu; T Usui; A Shimatsu; Y Ogawa; K Hosoda; T Akamizu; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

6.  Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.

Authors:  Noritoshi Nagaya; Junji Moriya; Yoshio Yasumura; Masaaki Uematsu; Fumiaki Ono; Wataru Shimizu; Kazuyuki Ueno; Masafumi Kitakaze; Kunio Miyatake; Kenji Kangawa
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase.

Authors:  Nicholas J Beaumont; Vernon O Skinner; Tricia M-M Tan; Bala S Ramesh; Dominic J Byrne; Gavin S MacColl; Jeff N Keen; Pierre M Bouloux; Dimitri P Mikhailidis; K Richard Bruckdorfer; Mark P Vanderpump; Kaila S Srai
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

9.  Pubertal development in Swiss boys.

Authors:  R H Largo; A Prader
Journal:  Helv Paediatr Acta       Date:  1983-08

10.  Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment.

Authors:  Damien R Ashby; Heather E Ford; Katie J Wynne; Alison M Wren; Kevin G Murphy; Mark Busbridge; Edwina A Brown; David H Taube; Mohammad A Ghatei; Frederick W K Tam; Stephen R Bloom; Peter Choi
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

View more
  21 in total

1.  Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones.

Authors:  Anja K Büscher; Metin Cetiner; Rainer Büscher; Anne-Margret Wingen; Berthold P Hauffa; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2012-06-05       Impact factor: 3.714

2.  Growth in children with chronic kidney disease: 13 years follow up study.

Authors:  Petar Salević; Pavle Radović; Nataša Milić; Radovan Bogdanović; Dušan Paripović; Aleksandra Paripović; Emilija Golubović; Biljana Milosević; Bilsana Mulić; Amira Peco-Antić
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

Review 3.  Nutritional management and growth in children with chronic kidney disease.

Authors:  Lesley Rees; Helen Jones
Journal:  Pediatr Nephrol       Date:  2012-07-24       Impact factor: 3.714

Review 4.  Assessment of nutritional status in children with chronic kidney disease and on dialysis.

Authors:  Antonio Mastrangelo; Fabio Paglialonga; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

Review 5.  Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?

Authors:  Mark D DeBoer
Journal:  Mol Cell Endocrinol       Date:  2011-02-25       Impact factor: 4.102

6.  High serum adiponectin concentration in children with chronic kidney disease.

Authors:  Kristina F Möller; Christina Dieterman; Lena Herich; Ilka A Klaassen; Markus J Kemper; Dirk E Müller-Wiefel
Journal:  Pediatr Nephrol       Date:  2011-08-09       Impact factor: 3.714

7.  Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.

Authors:  Nur Canpolat; Lale Sever; Ayse Agbas; Mehmet Tasdemir; Cigdem Oruc; Ozlem Balcı Ekmekci; Salim Caliskan
Journal:  Pediatr Nephrol       Date:  2018-07-06       Impact factor: 3.714

8.  Perceived appetite and clinical outcomes in children with chronic kidney disease.

Authors:  Frank W Ayestaran; Michael F Schneider; Frederick J Kaskel; Poyyapakkam R Srivaths; Patricia W Seo-Mayer; Marva Moxey-Mims; Susan L Furth; Bradley A Warady; Larry A Greenbaum
Journal:  Pediatr Nephrol       Date:  2016-02-08       Impact factor: 3.714

9.  Acylation of ghrelin is increased in heart failure and decreases post heart transplantation.

Authors:  Stanislava Zabarovskaja; Pamela Freda; Jill J Williams; Chandra Kunavarapu; John Lamanca; Donna Mancini; Lars H Lund
Journal:  Scand Cardiovasc J       Date:  2014-09-18       Impact factor: 1.589

Review 10.  Ghrelin and leptin pathophysiology in chronic kidney disease.

Authors:  Sujana S Gunta; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2012-12-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.